荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

未开盘 02-04 16:08:25

81.650

+0.400

+0.49%

最高83.600	最低79.600	成交量287.89万
今开80.850	昨收81.250	日振幅4.92%
总市值460.19亿	流通市值170.31亿	总股本5.64亿
成交额2.35亿	换手率1.38%	流通股本2.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":81.65,"timestamp":1770192505009,"preClose":81.25,"halted":0,"volume":2878914,"delay":0,"changeRate":0.004923076923076993,"floatShares":208581239,"shares":563608243,"eps":-3.0726336512995993,"marketStatus":"未开盘","change":0.4,"latestTime":"02-04 16:08:25","open":80.85,"high":83.6,"low":79.6,"amount":235458025,"amplitude":0.049231,"askPrice":81.75,"askSize":500,"bidPrice":81.65,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.9642401507019476,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":81.25,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":0.9198911000596602,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":102.8,"timestamp":1770188400000,"preClose":101.04,"halted":0,"volume":5259900,"delay":0,"premium":"-29.43"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2608013368","title":"每日卖空追踪 | 荣昌生物 02月04日卖空量成交5.95万股，卖空比例为2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608013368","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608013368?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193843,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间02月04日，涨0.49%，卖空量成交5.95万股，较上一交易日减少54.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163906a6d20734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163906a6d20734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2328871848.SGD","09995","BK1583","BK1574","LU1969619763.USD"],"gpt_icon":0},{"id":"2608368046","title":"荣昌生物02月04日主力净流入1040.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608368046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608368046?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192947,"startTime":"0","endTime":"0","summary":"02月04日, 荣昌生物股价涨0.49%，报收81.65元，成交金额2.4亿元，换手率1.38%，振幅4.92%，量比0.92。荣昌生物今日主力资金净流入1040.7万元，上一交易日主力净流出276.1万元。该股近5个交易日下跌6.44%，主力资金累计净流入418.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.2亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162035a6d1f2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162035a6d1f2a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","BK1574","LU1969619763.USD","09995","BK1583","BK1161"],"gpt_icon":0},{"id":"2608875572","title":"283只医药股披露2025年业绩预告：药明康德最能赚、创新药企业走向盈利分界线，疫苗企业业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2608875572","media":"每经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608875572?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:52","pubTimestamp":1770115974,"startTime":"0","endTime":"0","summary":"Wind数据显示，截至1月31日，共有283只医药股披露了2025年业绩预告。赛诺医疗预计，公司2025年归母净利润为4300万元至5000万元，同比增长2767%至3233%。此外，披露2025年度业绩预告的医药股中，药明康德预计净利润为191.51亿元，创公司上市以来的归母净利润新高。多家创新药企业预计扭亏、减亏披露业绩预告的创新药企中，不少企业出现净利扭亏、减亏的情形。此外，盟科药业、君实生物等创新药企虽未实现盈利，但已大幅减亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203185354a6ce4350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203185354a6ce4350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","LU0320764599.SGD","01877","02359","LU2242644610.SGD","06978","09969","BK1515","BK1583","BK1576","BK1574","LU2125910500.SGD","LU0708995583.HKD","LU0052750758.USD","LU1046422090.SGD","09939","BK1141","BK1161","09995"],"gpt_icon":0},{"id":"2608387145","title":"每日卖空追踪 | 荣昌生物 02月03日卖空量成交8.1万股，卖空比例为3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608387145?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107442,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间02月03日，涨1.12%，卖空量成交8.1万股，较上一交易日减少91.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163756a6cdbb2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163756a6cdbb2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1969619763.USD","BK1574","09995","BK1583","LU2328871848.SGD"],"gpt_icon":0},{"id":"2608849407","title":"【券商聚焦】交银国际维持荣昌生物(09995)买入评级 看好2026年主业利润率进一步改善的空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2608849407","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608849407?lang=zh_cn&edition=full","pubTime":"2026-02-03 13:29","pubTimestamp":1770096543,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，荣昌生物 发布2025年年度业绩预告，预计全年营业收入约32.5亿元，同比增长约89%；净利润约7.16 亿元，扣非净利润约7,850万元，均同比扭亏为盈。据公告，业绩高增长主因核心产品国内市场商业化持续放量、BD收入确认显著增厚利润端、运营效率持续优化。随着泰它西普和RC148出海后、更多研发费用由海外合作伙伴承担，该机构看好2026年主业利润率进一步改善的空间。该机构维持公司136港元的目标价，维持买入评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974464","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","09995"],"gpt_icon":0},{"id":"2608938717","title":"创新兑现+估值修复，医药生物强劲“吸金”","url":"https://stock-news.laohu8.com/highlight/detail?id=2608938717","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608938717?lang=zh_cn&edition=full","pubTime":"2026-02-03 09:23","pubTimestamp":1770081801,"startTime":"0","endTime":"0","summary":"近期，医药生物板块在资本市场上表现出强劲的“吸金”能力，市场情绪显著回暖。数据显示，截至1月30日，科创创新药ETF国泰已连续10个交易日获得资金净申购，区间净流入额达到6.67亿元。深入分析来看，当前医药板块的投资逻辑主要支撑于“创新兑现”与“估值修复”两大支柱。科创创新药ETF国泰紧密跟踪科创新药指数，聚焦龙头公司，创新药企占比超90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203092535a4752f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203092535a4752f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","LU2328871848.SGD","09995","LU1969619763.USD","BK1574"],"gpt_icon":0},{"id":"2608896737","title":"荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608896737","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608896737?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:25","pubTimestamp":1769999139,"startTime":"0","endTime":"0","summary":"1月30日，包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告，那么2025年这些药企战绩如何？而科兴制药更是预计，2025年归母净利润同比增长328.83%至455.89%，为1.35亿元至1.75亿元。科兴制药表示，创新药管线突破奠定业绩增长基础。与荣昌生物、科兴制药的强势增长不同，百利天恒、复旦张江等则面临不同程度的业绩压力，但各有应对与布局。各家创新药企业的业绩表现，背后是2025年国产创新药行业的结构性改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09995","BK1574","01349","06978","BK1515","01877","BK1191","LU1969619763.USD","LU2328871848.SGD","BK1583"],"gpt_icon":0},{"id":"2608384558","title":"港股异动 | 荣昌生物(09995)盈喜后涨近4% 预计25年度归母净利润约7.16亿元 公司盈利效率大幅改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2608384558","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608384558?lang=zh_cn&edition=full","pubTime":"2026-02-02 09:25","pubTimestamp":1769995522,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物盈喜后涨近4%，截至发稿，涨3.68%，报87.3港元，成交606.74万港元。消息面上，1月30日，荣昌生物发布公告，经公司财务部门初步测算，预计2025年度营业收入约人民币32.5亿元，与上年同期相比，将增加收入约人民币15.33亿元，同比增加约89%。公司预计2025年度实现归属于母公司所有者的净利润约人民币7.16亿元，与上年同期相比，实现扭亏为盈。综合多方面积极因素，公司盈利效率大幅改善，预计2025年度净利润将实现扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VT","688331","09995"],"gpt_icon":0},{"id":"2608887409","title":"医保数据发布再升级；多家药企发布业绩预告","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887409","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608887409?lang=zh_cn&edition=full","pubTime":"2026-02-02 08:04","pubTimestamp":1769990666,"startTime":"0","endTime":"0","summary":"政策动向医保数据发布再升级2月1日，国家医保局官微发文称，医保数据工作组是医保部门的一项创新性工作。数据发布活动组织一年多以来，各地发布内容不断丰富，发布形式更加多样，一些地方基于按病种付费改革开展病种专题分析，为疾病诊疗资源消耗“画像”，为医疗机构提供更加具体、好用的管理工具。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602023638025174.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602023638025174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0075","CDE","LU1223083913.SGD","BK1574","BK4017","LU2328871848.SGD","BK1161","09995","LU1328615791.USD","688331","BK0239","BK0028","BK0077","LU2148510915.USD","LU2580892789.USD","BK0196","LU1223082196.USD","000661","688506","LU1064130708.USD","LU2488822045.USD","LU2580892862.HKD","BK0057","BK1583","BK0046","LU1064131003.USD","LU1969619763.USD","LU1223082519.USD","300122","BK0188"],"gpt_icon":0},{"id":"2608072430","title":"每周股票复盘：荣昌生物（688331）预计2025年净利7.16亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072430","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608072430?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:32","pubTimestamp":1769880732,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，荣昌生物报收于102.25元，较上周的102.27元下跌0.02%。本周，荣昌生物1月30日盘中最高价报107.5元。业绩披露要点荣昌生物发布业绩预告，预计2025年全年归属净利润盈利约7.16亿元。公司公告汇总荣昌生物预计2025年度营业收入约325,000万元，同比增长约89%；归属于母公司所有者的净利润约71,600万元，实现扭亏为盈；扣除非经常性损益后的净利润约7,850万元，亦实现扭亏为盈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU2148510915.USD","LU1064131003.USD","688331","LU1969619763.USD","BK0239","LU2488822045.USD","BK1574","LU2328871848.SGD","BK1161","LU1064130708.USD","09995"],"gpt_icon":0},{"id":"1175718238","title":"荣昌生物2025年报营收32.5亿元，经调整净利润0.79亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175718238","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175718238?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:41","pubTimestamp":1769773308,"startTime":"0","endTime":"0","summary":"荣昌生物披露的2025年报显示，期内营收约为人民币325,000万元，同比增长约89%。经调整净利润由上一财年的亏损人民币150,764.24万元转为盈利约7,850万元，成功扭亏为盈。公司管理层将这一变化归因于两方面重要因素：其一，核心产品泰它西普和维迪西妥单抗在国内市场的销售收入快速提升；其二，对外技术授权交易带来显著收益，同时合作方承担相关研发投入，进一步减轻成本压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"2607401314","title":"荣昌生物：2025年全年预计净利润7.16亿元—7.16亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607401314","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607401314?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:25","pubTimestamp":1769765136,"startTime":"0","endTime":"0","summary":"南财智讯1月30日电，荣昌生物发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润约为71,600万元，实现扭亏为盈；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润约为7,850万元，实现扭亏为盈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303637048943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688331","09995"],"gpt_icon":0},{"id":"2607092682","title":"国产创新药BD交易呈现井喷式增长，2026年1月持续爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2607092682","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607092682?lang=zh_cn&edition=full","pubTime":"2026-01-30 11:51","pubTimestamp":1769745089,"startTime":"0","endTime":"0","summary":"近年来，国产创新药BD交易呈现井喷式增长，不少创新药扬帆出海，在国际舞台打开市场空间。数据显示，2025年中国创新药BD出海授权交易总金额达到1,356.55亿美元，交易总数达157起。本次交易总额最高可达10.58亿欧元。2025年8月，荣昌生物发布消息称，RC148用于晚期恶性实体肿瘤Ⅱ期的临床试验申请已获FDA批准。2026年1月国产创新药BD出海的密集突破，既是2025年爆发式增长态势的延续，也是中国创新药产业高质量发展的生动缩影。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130115551a4675992&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130115551a4675992&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06978","LU1969619763.USD","BK1583","LU2328871848.SGD","09995","BK1574"],"gpt_icon":0},{"id":"2607092579","title":"每日卖空追踪 | 荣昌生物 01月29日卖空量成交2万股，卖空比例为0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607092579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607092579?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675444,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间01月29日，跌2.7%，卖空量成交2万股，较上一交易日减少9.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164321a6bae715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164321a6bae715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","LU1969619763.USD","BK1583","BK1574","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2607667000","title":"荣昌生物01月29日遭主力抛售135.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607667000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607667000?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:16","pubTimestamp":1769674568,"startTime":"0","endTime":"0","summary":"01月29日, 荣昌生物股价跌2.70%，报收84.55元，成交金额2.1亿元，换手率1.22%，振幅4.95%，量比0.81。荣昌生物今日主力资金净流出135.9万元，上一交易日主力净流出177.2万元。该股近5个交易日下跌6.19%，主力资金累计净流入8705.2万元；近20日主力资金累计净流入3.0亿元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162715a6bad4af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162715a6bad4af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU1969619763.USD","BK1574","LU2328871848.SGD","BK1161","09995"],"gpt_icon":0},{"id":"2606326296","title":"【券商聚焦】招银国际：创新药出海趋势长期将延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2606326296","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606326296?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:17","pubTimestamp":1769404672,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨9.2%，跑赢MSCI中国指数5.6%。展望2026年，创新药出海趋势长期将延续，该机构将重点关注已出海管线的临床进展与数据兑现的核心催化。年初多个创新药BD交易落地，中国创新药出海的趋势向好。该机构认为，中国企业对于临床前分子的转让或将谨慎，未来中国出海分子将大多在具备中国早期临床试验数据的基础上达成，以获得更高的交易价值。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU1794554557.SGD","LU1242518931.SGD","LU1880383366.USD","06185","SG9999002463.SGD","LU1303224171.USD","09995","SG9999002562.SGD","02142","IE00B5MMRT66.SGD","LU0348825331.USD","159992","LU0043850808.USD","LU3063872942.SGD","LU2399975544.HKD","LU1960683339.HKD","BK1576","09688","LU0348784397.USD","01877","BK1500","06160","02269","LU0456827905.SGD","LU0417516902.SGD","LU0516423091.SGD","LU1226287529.USD","01177","LU0359201612.USD","LU0979878070.USD","LU1969619763.USD","IE00BZ08YS42.EUR","02616","LU2242644610.SGD","LU0051755006.USD","BK1588","LU0348767384.USD","LU1807302812.USD","LU0708995583.HKD","01093","IE00BZ08YT58.USD","LU0315179316.USD","01801","LU0516422440.USD","06978","LU0516422952.EUR","LU1226287875.USD","IE00B031HY20.USD","09926"],"gpt_icon":0},{"id":"2606122293","title":"3万亿赛道的估值锚点，彻底变了","url":"https://stock-news.laohu8.com/highlight/detail?id=2606122293","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606122293?lang=zh_cn&edition=full","pubTime":"2026-01-26 08:12","pubTimestamp":1769386320,"startTime":"0","endTime":"0","summary":"多只创新药ETF的年内最高涨幅突破50%，多家创新药企股价翻番。不过，我们发现经过验证的靶点，不同企业的BD交易授权下，资本市场也给出了不同反应。且2024年，美国FDA批准了同类首款药物Ensifentrine，为该靶点的成药性提供了关键验证。只不过与海思科不同，恒瑞医药在与GSK的交易公告后，其A股和H股股价均出现了显著上涨。据悉，恒瑞医药获得的5亿美元为纯现金首付款，可以立即确认业绩，展现了GSK对其资产价值的强烈认可和信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656147805&idx=1&sn=bc6bcda7f82ce0193ae3a090ba46cdc8&chksm=67838d5482c3a023e3be79b5567544c3a508a60a147222d217af39c881d77ba875ce4eab9a04&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4153","LU1064131003.USD","BK4532","688331","LU1969619763.USD","LU2328871848.SGD","LU1829250122.USD","BK4588","06978","BK1161","BK1583","LU1064130708.USD","LU2488822045.USD","BK1574","09995","BK4585","GSK.UK","GSK","BK4007","LU2148510915.USD","AA","BK0239"],"gpt_icon":0},{"id":"2606234089","title":"每周股票复盘：荣昌生物（688331）首次回购股份19.4144万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234089","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234089?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:04","pubTimestamp":1769277852,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，荣昌生物报收于102.27元，较上周的107.25元下跌4.64%。本周，荣昌生物1月19日盘中最高价报109.38元。本周关注点公司公告汇总：荣昌生物首次回购股份19.4144万股，支付资金总额2000.40万元。荣昌生物制药（烟台）股份有限公司完成2022年及2023年A股限制性股票激励计划相关权益归属，共计归属767,240股，涉及激励对象142人。股本总数由563,710,243股增至564,477,483股，实际控制人未发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","09995","LU2328871848.SGD","BK0239","BK1161","BK1574","LU2488822045.USD","LU1969619763.USD","LU1064131003.USD","688331","BK1583","LU1064130708.USD"],"gpt_icon":0},{"id":"2605840159","title":"每日卖空追踪 | 荣昌生物 01月23日卖空量成交3.95万股，卖空比例为0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605840159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605840159?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157044,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间01月23日，涨0.61%，卖空量成交3.95万股，较上一交易日减少95.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164158a6a44fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164158a6a44fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","BK1583","LU1969619763.USD","BK1161","09995","BK1574"],"gpt_icon":0},{"id":"2605401560","title":"荣昌生物01月23日获主力加仓6051.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605401560","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605401560?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156112,"startTime":"0","endTime":"0","summary":"01月23日, 荣昌生物股价涨0.61%，报收90.20元，成交金额3.7亿元，换手率1.93%，振幅4.24%，量比1.00。荣昌生物今日主力资金净流入6051.0万元，连续6日净流入，上一交易日主力净流入108.1万元。该股近5个交易日下跌7.98%，主力资金累计净流入8086.2万元；近20日主力资金累计净流入2.7亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161603a44d82cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161603a44d82cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09995","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0604},{"period":"1month","weight":0.027},{"period":"3month","weight":-0.0604},{"period":"6month","weight":0.262},{"period":"1year","weight":5.0481},{"period":"ytd","weight":0.134}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.169401},{"month":3,"riseRate":0.4,"avgChangeRate":-0.022811},{"month":4,"riseRate":0.8,"avgChangeRate":0.104301},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}